Dr. Zoubeidi interviewed for International Day of Women and Girls in Science

Date Posted: 
Dr. Amina Zoubeidi

Dr. Amina Zoubeidi was featured in articles on VCHRI News and Prostate Cancer Canada on February 11, 2019, the International Day of Women and Girls in Science.

The VCHRI News article, "Ask an expert: Who runs the (science) world?" contains interviews with three researchers at VCHRI who share their experiences and offer advice for the next generation of women scientists.

The Prostate Cancer Canada article, "First of its kind treatment for incurable prostate cancer" discusses Dr. Zoubeidi's discovery of BRN2 and work on the development of a BRN2 blocker for the treatment of neuroendocrine prostate cancer. This was the first female-lead project to receive a Translation Acceleration Grant from Prostate Cancer Canada and Movember. Additionally, Dr. Zoubedi and Dr. Beltran of Weill Cornell Medicine were awarded a 2017 Prostate Cancer Foundation Challenge Award for further BRN2 research.

Dr. Zoubeidi is a Senior Research Scientist, Vancouver Prostate Centre and Associate Professor, Department of Urologic Sciences, UBC. She has received many awards throughout her career, most recently receiving the 2018 UBC Faculty of Medicine Distinguished Achievement Award for Excellence in Basic Science Research.


A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC took place on Sunday June 16, 2019 in various locations across BC. The sponsorship page is still accepting donations;  click here to sponsor our Centre's team (opens in new window).



Work at the Vancouver Prostate Centre

Monday, July 8, 2019

Dr. Flannigan to lead clinical trial for scrotal pain treatment

Dr. Flannigan
Monday, June 3, 2019

Benefits Seen With Apalutamide Plus ADT in Metastatic Castration-Sensitive Prostate Cancer

Dr. Chi